BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 32079306)

  • 1. Untargeted HILIC-MS-Based Metabolomics Approach to Evaluate Coffee Roasting Process: Contributing to an Integrated Metabolomics Multiplatform.
    Pérez-Míguez R; Castro-Puyana M; Sánchez-López E; Plaza M; Marina ML
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32079306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis-mass spectrometry metabolic fingerprinting of green and roasted coffee.
    Pérez-Míguez R; Sánchez-López E; Plaza M; Marina ML; Castro-Puyana M
    J Chromatogr A; 2019 Nov; 1605():360353. PubMed ID: 31307792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimized Analytical Procedures for the Untargeted Metabolomic Profiling of Human Urine and Plasma by Combining Hydrophilic Interaction (HILIC) and Reverse-Phase Liquid Chromatography (RPLC)-Mass Spectrometry.
    Contrepois K; Jiang L; Snyder M
    Mol Cell Proteomics; 2015 Jun; 14(6):1684-95. PubMed ID: 25787789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two complementary reversed-phase separations for comprehensive coverage of the semipolar and nonpolar metabolome.
    Naser FJ; Mahieu NG; Wang L; Spalding JL; Johnson SL; Patti GJ
    Anal Bioanal Chem; 2018 Feb; 410(4):1287-1297. PubMed ID: 29256075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of underivatized silica and zwitterionic sulfobetaine hydrophilic interaction liquid chromatography stationary phases for global metabolomics of human plasma.
    Sonnenberg RA; Naz S; Cougnaud L; Vuckovic D
    J Chromatogr A; 2019 Dec; 1608():460419. PubMed ID: 31439439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A non-targeted metabolomic approach based on reversed-phase liquid chromatography-mass spectrometry to evaluate coffee roasting process.
    Pérez-Míguez R; Sánchez-López E; Plaza M; Castro-Puyana M; Marina ML
    Anal Bioanal Chem; 2018 Dec; 410(30):7859-7870. PubMed ID: 30345455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HILIC-MS for metabolomics: An attractive and complementary approach to RPLC-MS.
    Tang DQ; Zou L; Yin XX; Ong CN
    Mass Spectrom Rev; 2016 Sep; 35(5):574-600. PubMed ID: 25284160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Augmented region of interest for untargeted metabolomics mass spectrometry (AriumMS) of multi-platform-based CE-MS and LC-MS data.
    Naumann L; Haun A; Höchsmann A; Mohr M; Novák M; Flottmann D; Neusüß C
    Anal Bioanal Chem; 2023 Jul; 415(16):3137-3154. PubMed ID: 37225900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A large-scale analysis of targeted metabolomics data from heterogeneous biological samples provides insights into metabolite dynamics.
    Lee HJ; Kremer DM; Sajjakulnukit P; Zhang L; Lyssiotis CA
    Metabolomics; 2019 Jul; 15(7):103. PubMed ID: 31289941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of capillary electrophoresis-mass spectrometry and hydrophilic interaction chromatography-mass spectrometry for anionic metabolic profiling of urine.
    Kok MG; Somsen GW; de Jong GJ
    Talanta; 2015 Jan; 132():1-7. PubMed ID: 25476271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternate reversed-phase and hydrophilic interaction liquid chromatography coupled with mass spectrometry for broad coverage in metabolomics analysis.
    Lv W; Guo L; Zheng F; Wang Q; Wang W; Cui L; Ouyang Y; Liu X; Li E; Shi X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Sep; 1152():122266. PubMed ID: 32693368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isotope Labeling-Assisted Evaluation of Hydrophilic and Hydrophobic Liquid Chromatograph-Mass Spectrometry for Metabolomics Profiling.
    Xie B; Wang Y; Jones DR; Dey KK; Wang X; Li Y; Cho JH; Shaw TI; Tan H; Peng J
    Anal Chem; 2018 Jul; 90(14):8538-8545. PubMed ID: 29883117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unified-Hydrophilic-Interaction/Anion-Exchange Liquid Chromatography Mass Spectrometry (Unified-HILIC/AEX/MS): A Single-Run Method for Comprehensive and Simultaneous Analysis of Polar Metabolome.
    Nakatani K; Izumi Y; Takahashi M; Bamba T
    Anal Chem; 2022 Dec; 94(48):16877-16886. PubMed ID: 36426757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the technical variations and the suitability of a hydrophilic interaction liquid chromatography-high resolution mass spectrometry (ZIC-pHILIC-Exactive orbitrap) for clinical urinary metabolomics study.
    Zhang T; Watson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jun; 1022():199-205. PubMed ID: 27107246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross platform solutions to improve the zebrafish polar metabolome coverage using LC-QTOF MS: Optimization of separation mechanisms, solvent additives, and resuspension solvents.
    Xu M; Legradi J; Leonards P
    Talanta; 2021 Nov; 234():122688. PubMed ID: 34364485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of Mobile Phase Modifiers for Fast LC-MS-Based Untargeted Metabolomics and Lipidomics.
    Cajka T; Hricko J; Rudl Kulhava L; Paucova M; Novakova M; Kuda O
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase the accessibility and scale of targeted metabolomics: Construction of a human urinary metabolome-wide multiple reaction monitoring library using directly-coupled reversed-phase and hydrophilic interaction chromatography.
    Yan Z; Yan R
    Anal Chim Acta; 2015 Sep; 894():65-75. PubMed ID: 26423629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabonomics study of liver cancer based on ultra performance liquid chromatography coupled to mass spectrometry with HILIC and RPLC separations.
    Chen J; Wang W; Lv S; Yin P; Zhao X; Lu X; Zhang F; Xu G
    Anal Chim Acta; 2009 Sep; 650(1):3-9. PubMed ID: 19720165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary electrophoresis-mass spectrometry as a tool for Caenorhabditis elegans metabolomics research.
    Salzer L; Schmitt-Kopplin P; Witting M
    Metabolomics; 2023 Jun; 19(7):61. PubMed ID: 37351740
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.